Literature DB >> 7440180

Parotid cancer: a rational basis for treatment.

M E Johns.   

Abstract

Parotid gland cancers are uncommon neoplasms whose management is complicated by their variable histopathology, their equally variable clinical course, and the intricate relationship of the facial nerve to the parotid gland and potential threat to the muscles of facial expression. In order to expand the limited familiarity with this unusual cancer that any single surgeon may acquire, a review is presented of factors influencing survival, including histopathology, lymph node metastasis, facial nerve palsy, skin involvement, size (stage), recurrence, pain, deep lobe and distant metastasis. The personal experiences of the author, experiences at the University of Virginia, and those in the literature were reviewed to derive the principles of treatment based on the TNM staging system and histopathologic diagnosis.

Entities:  

Mesh:

Year:  1980        PMID: 7440180     DOI: 10.1002/hed.2890030207

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  7 in total

Review 1.  [Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-09       Impact factor: 1.284

Review 2.  [Salivary gland carcinomas Part II. Diagnosis and therapy].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

3.  Tumours of Deep Lobe of Parotid Gland: Our Experience.

Authors:  Arjun Dass; Nitin Gupta; S K Singhal; Hitesh Verma
Journal:  Indian J Surg       Date:  2014-04-15       Impact factor: 0.656

Review 4.  Parotidectomy for Parotid Cancer.

Authors:  Jennifer R Cracchiolo; Ashok R Shaha
Journal:  Otolaryngol Clin North Am       Date:  2016-02-17       Impact factor: 3.346

5.  Parotid cancer treatment with surgery followed by radiotherapy in Oxford over 15 years.

Authors:  Ketan Shah; Faisal Javed; Chris Alcock; Ketan A Shah; Pieter Pretorius; Chris A Milford
Journal:  Ann R Coll Surg Engl       Date:  2011-04       Impact factor: 1.891

6.  Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy.

Authors:  S Rodríguez-Cuevas; S Labastida; L Baena; F Gallegos
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  S100A4 overexpression proves to be independent marker for breast cancer progression.

Authors:  Nawfal I Ismail; Gurjeet Kaur; Hasnah Hashim; Mohammed S Hassan
Journal:  Cancer Cell Int       Date:  2008-09-05       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.